BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 34991588)

  • 1. Elevated levels of interleukin-12/23p40 may serve as a potential indicator of dysfunctional heart rate variability in type 2 diabetes.
    Wegeberg AM; Okdahl T; Riahi S; Ejskjaer N; Pociot F; Størling J; Brock B; Brock C
    Cardiovasc Diabetol; 2022 Jan; 21(1):5. PubMed ID: 34991588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory markers are associated with cardiac autonomic dysfunction in recent-onset type 2 diabetes.
    Herder C; Schamarek I; Nowotny B; Carstensen-Kirberg M; Straßburger K; Nowotny P; Kannenberg JM; Strom A; Püttgen S; Müssig K; Szendroedi J; Roden M; Ziegler D;
    Heart; 2017 Jan; 103(1):63-70. PubMed ID: 27481890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Level of serum IL-12 and its correlation with endothelial dysfunction, insulin resistance, proinflammatory cytokines and lipid profile in newly diagnosed type 2 diabetes.
    Mishra M; Kumar H; Bajpai S; Singh RK; Tripathi K
    Diabetes Res Clin Pract; 2011 Nov; 94(2):255-61. PubMed ID: 21855158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adiponectin, biomarkers of inflammation and changes in cardiac autonomic function: Whitehall II study.
    Hansen CS; Vistisen D; Jørgensen ME; Witte DR; Brunner EJ; Tabák AG; Kivimäki M; Roden M; Malik M; Herder C
    Cardiovasc Diabetol; 2017 Dec; 16(1):153. PubMed ID: 29195493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating Inflammatory Markers Are Inversely Associated with Heart Rate Variability Measures in Type 1 Diabetes.
    Wegeberg AL; Okdahl T; Fløyel T; Brock C; Ejskjaer N; Riahi S; Pociot F; Størling J; Brock B
    Mediators Inflamm; 2020; 2020():3590389. PubMed ID: 32908447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations between Adiponectin Gene Variability, Proinflammatory and Angiogenetic Markers: Implications for Microvascular Disease Development in Type 2 Diabetes Mellitus?
    Kollia C; Antonopoulos AS; Siasos G; Konsola T; Oikonomou E; Gouliopoulos N; Tsigkou V; Papapanagiotou A; Kassi E; Tentolouris N; Katsiki N; Vavuranakis M; Papavassiliou AG; Tousoulis D
    Curr Vasc Pharmacol; 2019; 17(2):204-208. PubMed ID: 29308741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular organ damage in type 2 diabetes mellitus: the role of lipids and inflammation.
    Kozakova M; Morizzo C; Goncalves I; Natali A; Nilsson J; Palombo C
    Cardiovasc Diabetol; 2019 May; 18(1):61. PubMed ID: 31077210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imbalanced low-grade inflammation and endothelial activation in patients with type 2 diabetes mellitus and erectile dysfunction.
    Araña Rosaínz Mde J; Ojeda MO; Acosta JR; Elías-Calles LC; González NO; Herrera OT; García Álvarez CT; Rodríguez EM; Báez ME; Seijas EÁ; Valdés RF
    J Sex Med; 2011 Jul; 8(7):2017-30. PubMed ID: 21554550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of heart rate variability (HRV) in subjects with type 2 diabetes mellitus with and without diabetic foot: correlations with endothelial dysfunction indices and markers of adipo-inflammatory dysfunction.
    Tuttolomondo A; Del Cuore A; La Malfa A; Casuccio A; Daidone M; Maida CD; Di Raimondo D; Di Chiara T; Puleo MG; Norrito R; Guercio G; Pinto A
    Cardiovasc Diabetol; 2021 Jul; 20(1):142. PubMed ID: 34261479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationships between reduced heart rate variability and pre-clinical cardiovascular disease in patients with type 2 diabetes.
    Cardoso CR; Moraes RA; Leite NC; Salles GF
    Diabetes Res Clin Pract; 2014 Oct; 106(1):110-7. PubMed ID: 25145830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review about biomarkers for the investigation of vascular function and impairment in diabetes mellitus.
    Derosa G; Maffioli P
    Vasc Health Risk Manag; 2016; 12():415-419. PubMed ID: 27877049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High and low vitamin D level is associated with cardiovascular autonomic neuropathy in people with Type 1 and Type 2 diabetes.
    Hansen CS; Fleischer J; Vistisen D; Ridderstråle M; Jensen JS; Jørgensen ME
    Diabet Med; 2017 Mar; 34(3):364-371. PubMed ID: 27696502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of progressive resistance training and weight loss versus weight loss alone on inflammatory and endothelial biomarkers in older adults with type 2 diabetes.
    Miller EG; Sethi P; Nowson CA; Dunstan DW; Daly RM
    Eur J Appl Physiol; 2017 Aug; 117(8):1669-1678. PubMed ID: 28597102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of selected adhesion molecule and proinflammatory cytokine levels in the vitreous body of patients with type 2 diabetes--role of the inflammatory-immune process in the pathogenesis of proliferative diabetic retinopathy.
    Adamiec-Mroczek J; Oficjalska-Młyńczak J
    Graefes Arch Clin Exp Ophthalmol; 2008 Dec; 246(12):1665-70. PubMed ID: 18682976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acupuncture Reduces Hypertrophy and Cardiac Fibrosis, and Improves Heart Function in Mice with Diabetic Cardiomyopathy.
    Ye Y; Birnbaum Y; Widen SG; Zhang Z; Zhu S; Bajaj M; Chen H
    Cardiovasc Drugs Ther; 2020 Dec; 34(6):835-848. PubMed ID: 32767170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ATF3 expression in cardiomyocytes preserves homeostasis in the heart and controls peripheral glucose tolerance.
    Kalfon R; Koren L; Aviram S; Schwartz O; Hai T; Aronheim A
    Cardiovasc Res; 2017 Feb; 113(2):134-146. PubMed ID: 28082453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased levels of inflammatory mediators and proinflammatory monocytes in patients with type I diabetes mellitus and nephropathy.
    Kolseth IB; Reine TM; Parker K; Sudworth A; Witczak BJ; Jenssen TG; Kolset SO
    J Diabetes Complications; 2017 Jan; 31(1):245-252. PubMed ID: 27452162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritis.
    Rho YH; Chung CP; Oeser A; Solus J; Asanuma Y; Sokka T; Pincus T; Raggi P; Gebretsadik T; Shintani A; Stein CM
    Arthritis Rheum; 2009 Nov; 61(11):1580-5. PubMed ID: 19877084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heart rate variability and biomarkers of systemic inflammation in patients with stable coronary heart disease: findings from the Heart and Soul Study.
    von Känel R; Carney RM; Zhao S; Whooley MA
    Clin Res Cardiol; 2011 Mar; 100(3):241-7. PubMed ID: 20857123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of vitamin D status resulted in amelioration of biomarkers of systemic inflammation in the subjects with type 2 diabetes.
    Shab-Bidar S; Neyestani TR; Djazayery A; Eshraghian MR; Houshiarrad A; Kalayi A; Shariatzadeh N; Khalaji N; Gharavi A
    Diabetes Metab Res Rev; 2012 Jul; 28(5):424-30. PubMed ID: 22344966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.